# Omega 3 Fatty Acids in Patients With Chronic Renal Disease

Study · id `cardio:ct-nct03280615` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03280615](<https://clinicaltrials.gov/study/NCT03280615>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03280615

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03280615. Randomized; triple masking; primary purpose treatment. Start 2017-09-20 (actual); primary completion 2018-10-31 (actual). Results posted on 2019-09-09.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03280615, source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)
- Started: 2017-09-20 (actual) (ClinicalTrials.gov record NCT03280615, source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)
- Primary completion: 2018-10-31 (actual) (ClinicalTrials.gov record NCT03280615, source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)
- Completion: 2018-10-31 (actual) (ClinicalTrials.gov record NCT03280615, source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)
- Results first posted: 2019-09-09 (ClinicalTrials.gov record NCT03280615, source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)
- Countries: Chile (ClinicalTrials.gov record NCT03280615, source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03280615-2019-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Omega 3 Fatty Acids in Patients With Chronic Renal Disease
- Condition: Renal Insufficiency, Chronic
- Intervention (Dietary supplement): Omega 3 fatty acids
- Intervention (Dietary supplement): Corn oil
- Lead sponsor: University of Chile
- Lead sponsor class: OTHER
- Collaborator: Servicio de Salud Metropolitano Sur Oriente
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 705ca3bea1c6552ba9d54ce4afc017a023dc9574ef2b8f7460d5a18ce0ccaefb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
